13F Insight
DOSSIER · 13F-HR · Q2 2026

MPM BioImpact LLC

$1.6B in tracked AUM across 37 positions as of Q2 2026.

MB
CIK 0001687078 · last filed Jun 30, 2026
Total AUM
$1.6B
as of Q2 2026
Holdings
37
—
positions
Whale Score
67
67
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

MPM BioImpact LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
CGEM
Cullinan Therapeutics, Inc.
$177M9.7M10.8%02
AKTS
Aktis Oncology, Inc.
$156M4.8M9.5%03
LQDA
Liquidia Corporation
$111M1.4M6.7%04
RVMD
Revolution Medicines, Inc.
$92M492K5.6%05
CORT
Corcept Therapeutics, Inc.
$67M771K4.1%06
EWTX
Edgewise Therapeutics Inc
$66M1.6M4.0%07
TVTX
Travere Therapeutics Inc
$64M1.1M3.9%08
DBVT
DBV Technologies S A
$60M3.7M3.7%09
TRVI
Trevi Therapeutics Inc
$57M3.1M3.5%10
ALMS
Alumis Inc
$57M2.0M3.5%

Filing history

2026Q2Jun 30
$1.6B▲ 26.6%
37 positionsView →2026Q1Mar 31
$1.3B▲ 48.2%
41 positionsView →2025Q4Dec 31
$874M▲ 90.3%
38 positionsView →2025Q3Sep 30
$459M▼ 20.4%
30 positionsView →2025Q2Jun 30
$577M▲ 37.6%
44 positionsLocked2025Q1Mar 31
$419M▼ 40.5%
35 positionsLocked2024Q4Dec 31
$704M▲ 5.7%
47 positionsLocked2024Q3Sep 30
$667M▲ 3.6%
43 positionsLocked2024Q2Jun 30
$644M▲ 3.5%
44 positionsLocked2024Q1Mar 31
$622M▲ 45.5%
38 positionsLocked2023Q4Dec 31
$427M▲ 14.1%
32 positionsLocked2023Q3Sep 30
$375M▼ 24.6%
32 positionsLocked
Showing 12 of 27